TY - JOUR A1 - Maurer, Julia A1 - Saibold, Anna A1 - Gerl, Katharina A1 - Koller, Michael A1 - Kölbl, Oliver A1 - Pukrop, Tobias A1 - Windschuettl, Sandra A1 - Einhell, Sabine A1 - Herrmann-Johns, Anne A1 - Raptis, Georgios A1 - Mueller, Karolina T1 - Systematic development of a patient-reported ONCOlogical-ROUTinE-Screening (ONCO-ROUTES) procedure at the University Cancer Center Regensburg JF - Journal of Cancer Research and Clinical Oncology N2 - Purpose The evaluation of treatment success and progression in oncology patient-reported outcomes (PROs) is playing an increasingly important role. Meanwhile, PROs are a component of the certification requirements of the German Cancer Society for oncology centers. PROs are used to provide supportive therapy. There is currently no instrument that fully covers the requirements. At the University Hospital Regensburg (UKR), a digital ONCOlogical-ROUTinE-Screening (ONCO-ROUTES) procedure was developed in order to assess the need for supportive therapy in a standardized way and to provide patients with supportive interventions tailored to their needs. Methods On the basis of current requirements and guidelines, the development of ONCO-ROUTES was supported by experts in focus groups and interviews, and digitalization was carried out in connection with the IT infrastructure. Results A Needs-based, Quality-of-life (QoL) and Symptoms Screening (NQS2) tool already established in the routine at the UKR was further developed into ONCO-ROUTES, which is made up of the domains therapy phase, nutrition, tobacco use, alcohol use, quality of life, general condition/functional status, physical activity, psychooncology, social services, and further support needs. By linking the digitized questionnaire to the hospital information system, the results are available for immediate use in routine operations and thus for the referral of patients for further supportive therapy. Conclusion The digital PRO application ONCO-ROUTES is designed to involve patients in monitoring additional supportive needs and thus, improves supportive interdisciplinary treatment. Y1 - 2024 U6 - https://doi.org/10.1007/s00432-024-05955-4 SN - 1432-1335 VL - 150 IS - 9 PB - Springer Science and Business Media LLC ER -